Dupilumab-induced serum sickness-like reaction: an unusual adverse effect in a patient with atopic eczema

J Eur Acad Dermatol Venereol. 2021 Jan;35(1):e30-e32. doi: 10.1111/jdv.16782. Epub 2020 Jul 27.

Authors

R Treudler¹, N Delaroque², M Puder³, J-C Simon¹, M Szardenings^{2

3}

Affiliations

¹ Department of Dermatology, Venereology and Allergology, Leipzig Interdisciplinary Allergy Centre - LICA, Universität Leipzig, Leipzig, Germany.
² Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany.
³ epitopic GmbH, Leipzig, Germany.

PMID: 32594596
DOI: 10.1111/jdv.16782

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized* / adverse effects
Dermatitis, Atopic* / drug therapy
Eczema*
Humans
Serum Sickness* / chemically induced

Substances

Antibodies, Monoclonal, Humanized
dupilumab